These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 33935281

  • 1. ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.
    Liu J, Cao F, Li X, Zhang L, Liu Z, Li X, Lin J, Han C.
    Cell Death Dis; 2021 May 02; 12(5):438. PubMed ID: 33935281
    [Abstract] [Full Text] [Related]

  • 2. ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
    Peng K, Ding D, Wang N, Du T, Wang L, Duan X.
    Mol Omics; 2023 Oct 30; 19(9):714-725. PubMed ID: 37431189
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression.
    Zhang D, Lin J, Chao Y, Zhang L, Jin L, Li N, He R, Ma B, Zhao W, Han C.
    J Exp Clin Cancer Res; 2018 Jul 28; 37(1):176. PubMed ID: 30055641
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
    Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR.
    Clin Exp Metastasis; 2017 Apr 28; 34(3-4):229-239. PubMed ID: 28289921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
    Huth S, Heise R, Vetter-Kauczok CS, Skazik C, Marquardt Y, Czaja K, Knüchel R, Merk HF, Dahl E, Baron JM.
    Exp Dermatol; 2015 Sep 28; 24(9):663-8. PubMed ID: 25809190
    [Abstract] [Full Text] [Related]

  • 10. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z, Yu Z, Wang J, Zhou L, Zhang J, Yao B, Dou J, Qiu Z, Huang C.
    Cell Physiol Biochem; 2018 Sep 28; 46(1):238-252. PubMed ID: 29587259
    [Abstract] [Full Text] [Related]

  • 11. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
    Mai C, Zhao JJ, Tang XF, Wang W, Pan K, Pan QZ, Zhang XF, Jiang SS, Zhao BW, Li YF, Xia JC, Zhou ZW.
    Med Oncol; 2014 Jul 28; 31(7):53. PubMed ID: 24913813
    [Abstract] [Full Text] [Related]

  • 12. Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression.
    Zhang L, Zhang L, Xia X, He S, He H, Zhao W.
    Oncotarget; 2016 May 24; 7(21):30990-1000. PubMed ID: 27105535
    [Abstract] [Full Text] [Related]

  • 13. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
    Rose M, Meurer SK, Kloten V, Weiskirchen R, Denecke B, Antonopoulos W, Deckert M, Knüchel R, Dahl E.
    Mol Carcinog; 2018 Feb 24; 57(2):167-181. PubMed ID: 28940371
    [Abstract] [Full Text] [Related]

  • 14. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W, Liu M, Su Y, Zhou X, Liu Y, Zhang X.
    Oncotarget; 2015 Dec 29; 6(42):44480-94. PubMed ID: 26517087
    [Abstract] [Full Text] [Related]

  • 15. The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.
    Rose M, Noetzel E, Kistermann J, Eschenbruch J, Rushrush S, Gan L, Knüchel R, Gaisa NT, Dahl E.
    Cells; 2021 Apr 28; 10(5):. PubMed ID: 33924987
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
    Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E.
    Carcinogenesis; 2014 Mar 28; 35(3):727-36. PubMed ID: 24265292
    [Abstract] [Full Text] [Related]

  • 17. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
    Himmelfarb M, Klopocki E, Grube S, Staub E, Klaman I, Hinzmann B, Kristiansen G, Rosenthal A, Dürst M, Dahl E.
    Cancer Lett; 2004 Feb 10; 204(1):69-77. PubMed ID: 14744536
    [Abstract] [Full Text] [Related]

  • 18. Inter-α-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Is a Natural Stabilizer of Hyaluronan That Modulates Biological Processes in the Skin.
    Huth S, Huth L, Marquardt Y, Fietkau K, Dahl E, Esser PR, Martin SF, Heise R, Merk HF, Baron JM.
    Skin Pharmacol Physiol; 2020 Feb 10; 33(4):198-206. PubMed ID: 32799206
    [Abstract] [Full Text] [Related]

  • 19. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration.
    Kosinski J, Sechi A, Hain J, Villwock S, Ha SA, Hauschulz M, Rose M, Steib F, Ortiz-Brüchle N, Heij L, Maas SL, van der Vorst EPC, Knoesel T, Altendorf-Hofmann A, Simon R, Sauter G, Bednarsch J, Jonigk D, Dahl E.
    Mol Oncol; 2024 Jun 10; 18(6):1486-1509. PubMed ID: 38375974
    [Abstract] [Full Text] [Related]

  • 20. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M, Montagnani V, Stecca B.
    Oncogene; 2017 Jun 08; 36(23):3322-3333. PubMed ID: 28068326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.